about
Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cellsRedox control of protein degradationClinical Relevance of Biomarkers of Oxidative StressPharmacology and Clinical Drug Candidates in Redox MedicineRedox control of microglial function: molecular mechanisms and functional significanceReactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical IndicationsAntioxidants in Translational MedicineProlonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo.Analysis of growth components in Allium roots.Heme oxygenase-1 induction modulates microsomal prostaglandin E synthase-1 expression and prostaglandin E(2) production in osteoarthritic chondrocytes.Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1Effects of Nrf2 deficiency on bone microarchitecture in an experimental model of osteoporosisTranscription factors NRF2 and NF-κB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation.Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol.The PTEN/NRF2 axis promotes human carcinogenesisCannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's diseaseStructural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis.Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity.Protein tyrosine phosphatase 1B modulates GSK3β/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity.Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections.Role of microglial redox balance in modulation of neuroinflammation.Regulation of heme oxygenase-1 gene expression through the phosphatidylinositol 3-kinase/PKC-zeta pathway and Sp1.Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β-TrCP.Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice.WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes.Agmatine induces Nrf2 and protects against corticosterone effects in hippocampal neuronal cell line.Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression.Nuclear import and export signals control the subcellular localization of Nurr1 protein in response to oxidative stress.SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner.Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: modulation by the Nrf2/Trx axis.Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection.Activation of autophagy in macrophages by pro-resolving lipid mediators.Nrf2-mediated haeme oxygenase-1 up-regulation induced by cobalt protoporphyrin has antinociceptive effects against inflammatory pain in the formalin test in mice.Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2.The probability of G1 cells to enter into S increases with their size while S length decreases with cell enlargement in Allium cepa.Uneven distribution of protein kinase C-alpha and -beta isozymes in human sarcomas and carcinomas.Expression of protein kinase CI in NIH 3T3 cells increases its growth response to specific activators.Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative stress conditions by a 'drug-prodrug' mechanism of action
P50
Q24323027-14C1793D-96CC-4A5C-828A-A388AC15ECC5Q26783566-25DC3965-1E48-4A86-BB13-CC2F6B30FBF4Q26785512-86DD2F6F-2437-495C-8ED4-D9D1BB2BD0C0Q26785525-61565206-44F9-4151-8C30-D8275F601BD1Q27000279-7DEF3727-C0AD-4E79-B6E6-CF6CA0929295Q27024762-C5A0EBBA-5A9D-4C71-AA2A-839C10882444Q28394550-DEAD02A6-F4E4-4476-A885-7A1A8144F6D4Q30506148-F5E3640C-C817-4EA0-B055-D624E5F95BA6Q33288892-C999F197-29B1-4EE7-8DB7-8F26FD149A59Q33357045-703A3A91-CF4B-4B7E-BFC5-969804B8C5F0Q33442445-37343CD7-2984-4BD4-8E8A-29332A4A65FEQ33646741-14045B0C-236A-4804-9762-30107B641C45Q33999556-02AE526B-4E5E-4FAC-B9B4-2EC8AD5A623DQ34075866-EC45CB74-64BC-44AD-99D7-117220BD8B22Q34544145-4DCBC6FB-5330-4351-BFF5-76C370DB789AQ34579435-700ECCC3-32AB-4209-995D-B08F2C27F2C2Q34627188-BB250B38-1A16-4257-A1DE-BDAA00FCF839Q36172880-1FEF3D9E-A3FC-4008-9DE1-4B419E8088A4Q36467640-4F893F23-E2D5-4F75-8208-B1B69E6BAF06Q36907101-AA50E775-E2CC-4FD2-AF50-CFC1D108C613Q37090263-CDC294C9-B093-4B3F-B10B-FC39777313EDQ37440658-DAF5F67D-14F1-4319-9DF5-2E413D04F711Q38311856-0FA5D6D0-7658-40FF-9897-471473D57A7DQ38456402-2B839CBE-8BBF-465F-9CFD-632778817C55Q38875865-2B14C8E5-DBF4-47F3-A492-633163574EF5Q38945976-97D38F86-E98B-4897-AC3F-74A2108270C2Q38969497-FF479533-9E8B-4D4F-A9F5-9C902A7A3638Q39042187-52D851F5-755D-4E25-89D4-163F59C55263Q39217465-93C0F65E-E60C-43BA-BF0B-F2FB4EAE1F04Q39606140-8F3ED886-243A-4DD9-A365-587FDC6A5600Q39732353-09F58280-58E5-4A18-AB4C-3E9D32A880F0Q39775786-D4623A84-C3C4-49C6-BE93-DA26E451EEBBQ39832626-3C00F9B5-E224-4B97-9460-C12689CF6FC8Q39961845-4F1FD1FA-7D53-4D28-829B-D8DD42BC22CEQ40061304-073FD2C1-39F7-4799-839B-74E3E732F05FQ40301567-D151BF1F-F31F-4F2A-9BF2-D2E3D745A5CDQ41214341-5F95711D-0A26-4ECB-94F7-8A45FBCD0415Q41463332-A00E12E5-62A1-4F42-864D-63A288AFD0CEQ41747283-751A64ED-D97A-4F86-B910-99007EC84ABBQ42107527-3E067AC9-9E25-4E6F-8377-A6413EF8F65E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonio Cuadrado
@ast
Antonio Cuadrado
@en
Antonio Cuadrado
@es
Antonio Cuadrado
@nl
Antonio Cuadrado
@sl
type
label
Antonio Cuadrado
@ast
Antonio Cuadrado
@en
Antonio Cuadrado
@es
Antonio Cuadrado
@nl
Antonio Cuadrado
@sl
prefLabel
Antonio Cuadrado
@ast
Antonio Cuadrado
@en
Antonio Cuadrado
@es
Antonio Cuadrado
@nl
Antonio Cuadrado
@sl
P106
P1153
7005588564
P21
P31
P496
0000-0002-3444-9012